XJPX4925
Market cap39mUSD
Jan 16, Last price
1,625.00JPY
1D
0.00%
1Q
-15.36%
Jan 2017
-58.23%
Name
Haba Laboratories Inc
Chart & Performance
Profile
HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products comprise shampoos, conditioners, soaps, and hair and hand treatment products. The company sells its products through mail order, shops, drug/variety stores, and internet. It has approximately 70 HABA shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was founded in 1983 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 12,324,210 2.38% | 12,038,052 -6.75% | 12,908,861 -9.78% | |||||||
Cost of revenue | 12,511,871 | 12,296,220 | 12,763,605 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (187,661) | (258,168) | 145,256 | |||||||
NOPBT Margin | 1.13% | |||||||||
Operating Taxes | 275,315 | 159,201 | 2,075 | |||||||
Tax Rate | 1.43% | |||||||||
NOPAT | (462,976) | (417,369) | 143,181 | |||||||
Net income | (2,118,627) 199.30% | (707,865) 163.12% | (269,030) -224.31% | |||||||
Dividends | (151,171) | (151,282) | (151,122) | |||||||
Dividend yield | 1.92% | 1.72% | 1.85% | |||||||
Proceeds from repurchase of equity | (400,064) | |||||||||
BB yield | 4.90% | |||||||||
Debt | ||||||||||
Debt current | 1,354,720 | 1,001,091 | 1,085,040 | |||||||
Long-term debt | 1,000,360 | 1,031,752 | 1,472,843 | |||||||
Deferred revenue | (76,705) | (75,406) | ||||||||
Other long-term liabilities | 59,118 | 51,412 | 43,164 | |||||||
Net debt | (1,615,979) | (3,062,483) | (3,433,026) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (587,921) | 55,956 | 1,714,447 | |||||||
CAPEX | (154,000) | (288,650) | (187,505) | |||||||
Cash from investing activities | (441,788) | (214,402) | (216,492) | |||||||
Cash from financing activities | 171,065 | (676,322) | (1,512,977) | |||||||
FCF | 65,612 | 31,009 | 1,720,341 | |||||||
Balance | ||||||||||
Cash | 3,959,197 | 4,817,842 | 5,651,289 | |||||||
Long term investments | 11,862 | 277,484 | 339,620 | |||||||
Excess cash | 3,354,848 | 4,493,423 | 5,345,466 | |||||||
Stockholders' equity | 8,830,470 | 11,097,018 | 11,961,041 | |||||||
Invested Capital | 7,566,448 | 8,098,500 | 8,694,497 | |||||||
ROIC | 1.49% | |||||||||
ROCE | 1.03% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 3,782 | 3,782 | 3,782 | |||||||
Price | 2,077.00 -10.86% | 2,330.00 7.82% | 2,161.00 -52.56% | |||||||
Market cap | 7,854,215 -10.86% | 8,810,939 7.82% | 8,171,917 -52.56% | |||||||
EV | 6,238,236 | 5,748,456 | 4,738,891 | |||||||
EBITDA | 331,609 | 301,488 | 853,334 | |||||||
EV/EBITDA | 18.81 | 19.07 | 5.55 | |||||||
Interest | 9,731 | 6,055 | 7,170 | |||||||
Interest/NOPBT | 4.94% |